FDA commissioner Robert Califf

FDA Commissioner Robert Califf's Thursday testimony sparked new conversations about the future of cannabis in the U.S. particularly concerning its medical and recreational classifications. In a recent note, senior analyst Pablo Zuanic from Zuanic & Associates highlights the...

In a House Oversight and Accountability Committee hearing Thursday, the commissioner of the Food and Drug Administration (FDA), Robert Califf faced a barrage of questions spanning various critical issues, from lead contamination in baby food to the regulation of hemp and cannabis-derived products...